Invitation to Vimian’s year-end report for 2023 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Läs mer: Investera i räntebärande lån – Historisk årlig avkastning på 9,9 % (annons)

Pressmeddelande

Invitation to Vimian’s year-end report for 2023

MFN Publicerad: 05 Feb 11:00
Vimian Group

Vimian Group AB will publish its year-end report for 2023 on Thursday, 15 February 2024, at 07.45 (CET). An audiocast will be organised for investors, analysts and media, on the same day at 09.00 (CET).

CEO Patrik Eriksson and CFO Carl-Johan Zetterberg Boudrie, will present and comment on the report. In addition, Guy Spörri, CEO of Vimian’s MedTech segment Movora, will provide a brief overview of Movora. The audiocast will be held in English and include a question-and-answer session.

To attend the telephone conference:
Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
https://conference.financialhearings.com/teleconference/?id=50046536

To attend the webcast:
Link: https://ir.financialhearings.com/vimian-group-q4-report-2023

Related presentation materials will be available on Vimian’s website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
[email protected]
+46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 90 markets, has 1,000 employees and annual revenues of approximately EUR 280 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.

Attachments

Invitation to Vimian’s year-end report for 2023

Bifogade filer

Invitation to Vimian’s year-end report for 2023https://storage.mfn.se/45c584ad-b2ed-414b-ab26-9b4f453ef3df/invitation-to-vimians-year-end-report-for-2023.pdf

Nyheter om Vimian Group

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

Jämförelse: Vilken är Sveriges bästa fondrobot?Guide: Så börjar du spara i fonder som nybörjareTopplistor: Fonderna med bäst avkastning just nu
STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Vimian Group

Senaste nytt